This topic contains a solution. Click here to go to the answer

Author Question: PD is an 11-month-old M with phenylketonuria. His mother brought him in to visit you at an ... (Read 45 times)

eruditmonkey@yahoo.com

  • Hero Member
  • *****
  • Posts: 546
PD is an 11-month-old M with phenylketonuria. His mother brought him in to visit you at an outpatient nutrition center in the local pediatric hospital. LT: 28 inches WT: 8.7 kg Should PD's mom not be compliant with her diet, PD could potentially develop all of the following except:
 a. mental retardation.
  b. seizures.
  c. tyrosine deficiency.
  d. eczema.

Question 2

PD is an 11-month-old M with phenylketonuria. His mother brought him in to visit you at an outpatient nutrition center in the local pediatric hospital. LT: 28 inches WT: 8.7 kg This Phe restriction should achieve optimal blood Phe levels of:
 a. 120-900 umol/L.
  b. 120-360 umol/L.
  c. 500-900 umol/L.
  d. 750-900 umol/L.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

apple

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

c

Answer to Question 2

b





 

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

For a complete list of videos, visit our video library